Healthways Inc. (HWAY) Given Outperform Rating at Barrington Research
Healthways Inc. (NASDAQ:HWAY)‘s stock had its “outperform” rating reiterated by equities researchers at Barrington Research in a research report issued on Thursday.
Several other research firms have also commented on HWAY. Zacks Investment Research upgraded shares of Healthways from a “hold” rating to a “buy” rating and set a $29.00 price objective for the company in a research note on Wednesday, September 21st. Barclays PLC upgraded shares of Healthways from an “underweight” rating to an “equal weight” rating and boosted their price objective for the stock from $12.00 to $27.00 in a research note on Monday, August 22nd. Jefferies Group set a $26.00 price objective on shares of Healthways and gave the stock a “hold” rating in a research note on Thursday, August 18th. FBR & Co upped their price target on shares of Healthways from $16.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, August 10th. Finally, Piper Jaffray Cos. upped their price target on shares of Healthways from $15.00 to $25.50 and gave the company an “overweight” rating in a research note on Wednesday, August 10th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $24.21.
Shares of Healthways (NASDAQ:HWAY) traded up 0.80% on Thursday, hitting $25.20. 155,413 shares of the stock traded hands. Healthways has a one year low of $9.18 and a one year high of $27.30. The stock has a 50 day moving average of $25.35 and a 200 day moving average of $16.32. The company’s market cap is $925.80 million.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/healthways-inc-hway-given-outperform-rating-at-barrington-research.html
Healthways (NASDAQ:HWAY) last posted its quarterly earnings data on Tuesday, August 9th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.01 by $0.53. The firm earned $125 million during the quarter, compared to analyst estimates of $186.88 million. Healthways had a negative net margin of 31.32% and a positive return on equity of 8.83%. Healthways’s revenue was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.11 EPS. Equities analysts anticipate that Healthways will post $2.11 earnings per share for the current year.
In other news, Director Mary Jane England sold 3,816 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $24.78, for a total value of $94,560.48. Following the sale, the director now directly owns 39,068 shares of the company’s stock, valued at approximately $968,105.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 14.01% of the stock is currently owned by insiders.
Hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP increased its stake in Healthways by 8.2% in the second quarter. Dimensional Fund Advisors LP now owns 3,058,854 shares of the company’s stock valued at $35,330,000 after buying an additional 230,768 shares during the period. Vanguard Group Inc. increased its stake in Healthways by 6.0% in the second quarter. Vanguard Group Inc. now owns 2,622,631 shares of the company’s stock valued at $30,292,000 after buying an additional 148,879 shares during the period. BlackRock Fund Advisors increased its stake in Healthways by 4.0% in the second quarter. BlackRock Fund Advisors now owns 2,341,455 shares of the company’s stock valued at $27,044,000 after buying an additional 90,444 shares during the period. Royce & Associates LP increased its stake in Healthways by 1.1% in the second quarter. Royce & Associates LP now owns 913,204 shares of the company’s stock valued at $10,548,000 after buying an additional 10,000 shares during the period. Finally, Rutabaga Capital Management LLC MA increased its stake in Healthways by 359.7% in the second quarter. Rutabaga Capital Management LLC MA now owns 866,087 shares of the company’s stock valued at $10,003,000 after buying an additional 677,677 shares during the period. 92.52% of the stock is currently owned by institutional investors and hedge funds.
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.